Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
8 Patents
#344 in Beijing
#3,476 in China
Gan & Lee Pharmaceuticals
Forward Citations = 3
17 inventors:
Gan & Lee Pharmaceuticals
Calculating rank
% Expired Patents = 37.5
EPO Patents = 3
Trademarks = 10
Forward Citations = 3
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Wei Chen (3 out of 164 patents)
Lei Yin (3 out of 5 patents)
Wenjian Liu (3 out of 5 patents)
4. Heng Li (3 out of 11 patents)
5. Zhongru Gan (3 out of 3 patents)
6. Yining Zhang (3 out of 3 patents)
7. Fangkai Xue (3 out of 3 patents)
8. Bin Mu (3 out of 3 patents)
9. Jianghong Niu (3 out of 3 patents)
10. Lingyu Cai (3 out of 3 patents)
11. Dianxi Zhu (2 out of 2 patents)
12. Yin Lei (1 out of 1 patent)
13. Yao Zhenglin (1 out of 1 patent)
14. Li Heng (1 out of 1 patent)
15. Wenjie Li (1 out of 7 patents)
8 patents:
Company Overview
Gan & Lee Pharmaceuticals is a leading biopharmaceutical company dedicated to the research, development, production, and commercialization of insulin and diabetes therapeutics. With a focus on innovation and quality, Gan & Lee is committed to improving the lives of patients worldwide. The company's extensive portfolio includes a range of insulin products as well as other treatments for diabetes and related conditions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gan & Lee Pharmaceuticals. Retrieved from https://idiyas.com/company/gan-and-lee-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]